This review highlights the differential metabolic impacts of various adipose depots and the potential of tetradecylthioacetic acid (TTA) to modulate mitochondrial function and reduce specific fat depots.
Answers are grounded in this paper and cite their sources.
TTA effects on adipose depots remain exploratory; hypothesis-generating and should not yet change practice.
Adipose tissue metabolism is closely linked to insulin resistance, and differential fat distributions are associated with disorders like hypertension, diabetes, and cardiovascular disease. Adipose tissues vary in their impact on metabolic risk due to diverse gene expression profiles, leading to differences in lipolysis and in the production and release of adipokines and cytokines, thereby affecting the function of other tissues. In this paper, the roles of the various adipose tissues in obesity are summarized, with particular focus on mitochondrial function. In addition, we discuss how a functionally mitochondrial-targeted compound, the modified fatty acid tetradecylthioacetic acid (TTA), can influence mitochondrial function and decrease the size of specific fat depots.
No takes yet. Share an insight, caveat, or question.
Bjørndal et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: